Details of the Drug | DrugMAP

General Information of Drug (ID: DMQLJU2)

Drug Name	Imidazo[1,2-b]pyridazine acetamide derivative 7
Synonyms	PMID27607364-Compound-152
Drug Type	Small molecular drug
Structure
Structure	3D MOL			2D MOL
#Ro5 Violations (Lipinski): 0	Molecular Weight (mw)			352.4
	Logarithm of the Partition Coefficient (xlogp)			2.6
	Rotatable Bond Count (rotbonds)			5
	Hydrogen Bond Donor Count (hbonddonor)			1
	Hydrogen Bond Acceptor Count (hbondacc)			4
Chemical Identifiers	Formula C20H24N4O2 IUPAC Name N,N-diethyl-2-[2-(4-hydroxyphenyl)-6,8-dimethylimidazo[1,2-b]pyridazin-3-yl]acetamide Canonical SMILES CCN(CC)C(=O)CC1=C(N=C2N1N=C(C=C2C)C)C3=CC=C(C=C3)O InChI InChI=1S/C20H24N4O2/c1-5-23(6-2)18(26)12-17-19(15-7-9-16(25)10-8-15)21-20-13(3)11-14(4)22-24(17)20/h7-11,25H,5-6,12H2,1-4H3 InChIKey AHZVLZZEKQYWAC-UHFFFAOYSA-N
Cross-matching ID	PubChem CID 44197028 TTD ID D0K3MV

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Translocator protein (TSPO)	TTPTXIN	TSPO_HUMAN	Ligand	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).Expert Opin Ther Pat. 2016 Nov;26(11):1325-1351.